Recombinant herpesvirus glycoprotein G improves the protective immune response to Helicobacter pylori vaccination in a mouse model of disease.

Alphaherpesviruses, which have co-evolved with their hosts for more than 200 million years, evade and subvert host immune responses, in part, by expression of immuno-modulatory molecules. Alphaherpesviruses express a single, broadly conserved chemokine decoy receptor, glycoprotein G (gG), which can...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Louise Baker, Andre M L Chitas, Carol A Hartley, Mauricio J C Coppo, Paola K Vaz, Andrew Stent, James R Gilkerson, Joanne M Devlin, Alison L Every
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e77ce459c55a4e2189fdf39e8217553b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e77ce459c55a4e2189fdf39e8217553b
record_format dspace
spelling oai:doaj.org-article:e77ce459c55a4e2189fdf39e8217553b2021-11-18T08:20:55ZRecombinant herpesvirus glycoprotein G improves the protective immune response to Helicobacter pylori vaccination in a mouse model of disease.1932-620310.1371/journal.pone.0096563https://doaj.org/article/e77ce459c55a4e2189fdf39e8217553b2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24794215/?tool=EBIhttps://doaj.org/toc/1932-6203Alphaherpesviruses, which have co-evolved with their hosts for more than 200 million years, evade and subvert host immune responses, in part, by expression of immuno-modulatory molecules. Alphaherpesviruses express a single, broadly conserved chemokine decoy receptor, glycoprotein G (gG), which can bind multiple chemokine classes from multiple species, including human and mouse. Previously, we demonstrated that infection of chickens with an infectious laryngotracheitis virus (ILTV) mutant deficient in gG resulted in altered host immune responses compared to infection with wild-type virus. The ability of gG to disrupt the chemokine network has the potential to be used therapeutically. Here we investigated whether gG from ILTV or equine herpesvirus 1 (EHV-1) could modulate the protective immune response induced by the Helicobacter pylori vaccine antigen, catalase (KatA). Subcutaneous immunisation of mice with KatA together with EHV-1 gG, but not ILTV gG, induced significantly higher anti-KatA IgG than KatA alone. Importantly, subcutaneous or intranasal immunisation with KatA and EHV-1 gG both resulted in significantly lower colonization levels of H. pylori colonization following challenge, compared to mice vaccinated with KatA alone. Indeed, the lowest colonization levels were observed in mice vaccinated with KatA and EHV-1 gG, subcutaneously. In contrast, formulations containing ILTV gG did not affect H. pylori colonisation levels. The difference in efficacy between EHV-1 gG and ILTV gG may reflect the different spectrum of chemokines bound by the two proteins. Together, these data indicate that the immuno-modulatory properties of viral gGs could be harnessed for improving immune responses to vaccine antigens. Future studies should focus on the mechanism of action and whether gG may have other therapeutic applications.Louise BakerAndre M L ChitasCarol A HartleyMauricio J C CoppoPaola K VazAndrew StentJames R GilkersonJoanne M DevlinAlison L EveryPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 5, p e96563 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Louise Baker
Andre M L Chitas
Carol A Hartley
Mauricio J C Coppo
Paola K Vaz
Andrew Stent
James R Gilkerson
Joanne M Devlin
Alison L Every
Recombinant herpesvirus glycoprotein G improves the protective immune response to Helicobacter pylori vaccination in a mouse model of disease.
description Alphaherpesviruses, which have co-evolved with their hosts for more than 200 million years, evade and subvert host immune responses, in part, by expression of immuno-modulatory molecules. Alphaherpesviruses express a single, broadly conserved chemokine decoy receptor, glycoprotein G (gG), which can bind multiple chemokine classes from multiple species, including human and mouse. Previously, we demonstrated that infection of chickens with an infectious laryngotracheitis virus (ILTV) mutant deficient in gG resulted in altered host immune responses compared to infection with wild-type virus. The ability of gG to disrupt the chemokine network has the potential to be used therapeutically. Here we investigated whether gG from ILTV or equine herpesvirus 1 (EHV-1) could modulate the protective immune response induced by the Helicobacter pylori vaccine antigen, catalase (KatA). Subcutaneous immunisation of mice with KatA together with EHV-1 gG, but not ILTV gG, induced significantly higher anti-KatA IgG than KatA alone. Importantly, subcutaneous or intranasal immunisation with KatA and EHV-1 gG both resulted in significantly lower colonization levels of H. pylori colonization following challenge, compared to mice vaccinated with KatA alone. Indeed, the lowest colonization levels were observed in mice vaccinated with KatA and EHV-1 gG, subcutaneously. In contrast, formulations containing ILTV gG did not affect H. pylori colonisation levels. The difference in efficacy between EHV-1 gG and ILTV gG may reflect the different spectrum of chemokines bound by the two proteins. Together, these data indicate that the immuno-modulatory properties of viral gGs could be harnessed for improving immune responses to vaccine antigens. Future studies should focus on the mechanism of action and whether gG may have other therapeutic applications.
format article
author Louise Baker
Andre M L Chitas
Carol A Hartley
Mauricio J C Coppo
Paola K Vaz
Andrew Stent
James R Gilkerson
Joanne M Devlin
Alison L Every
author_facet Louise Baker
Andre M L Chitas
Carol A Hartley
Mauricio J C Coppo
Paola K Vaz
Andrew Stent
James R Gilkerson
Joanne M Devlin
Alison L Every
author_sort Louise Baker
title Recombinant herpesvirus glycoprotein G improves the protective immune response to Helicobacter pylori vaccination in a mouse model of disease.
title_short Recombinant herpesvirus glycoprotein G improves the protective immune response to Helicobacter pylori vaccination in a mouse model of disease.
title_full Recombinant herpesvirus glycoprotein G improves the protective immune response to Helicobacter pylori vaccination in a mouse model of disease.
title_fullStr Recombinant herpesvirus glycoprotein G improves the protective immune response to Helicobacter pylori vaccination in a mouse model of disease.
title_full_unstemmed Recombinant herpesvirus glycoprotein G improves the protective immune response to Helicobacter pylori vaccination in a mouse model of disease.
title_sort recombinant herpesvirus glycoprotein g improves the protective immune response to helicobacter pylori vaccination in a mouse model of disease.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/e77ce459c55a4e2189fdf39e8217553b
work_keys_str_mv AT louisebaker recombinantherpesvirusglycoproteingimprovestheprotectiveimmuneresponsetohelicobacterpylorivaccinationinamousemodelofdisease
AT andremlchitas recombinantherpesvirusglycoproteingimprovestheprotectiveimmuneresponsetohelicobacterpylorivaccinationinamousemodelofdisease
AT carolahartley recombinantherpesvirusglycoproteingimprovestheprotectiveimmuneresponsetohelicobacterpylorivaccinationinamousemodelofdisease
AT mauriciojccoppo recombinantherpesvirusglycoproteingimprovestheprotectiveimmuneresponsetohelicobacterpylorivaccinationinamousemodelofdisease
AT paolakvaz recombinantherpesvirusglycoproteingimprovestheprotectiveimmuneresponsetohelicobacterpylorivaccinationinamousemodelofdisease
AT andrewstent recombinantherpesvirusglycoproteingimprovestheprotectiveimmuneresponsetohelicobacterpylorivaccinationinamousemodelofdisease
AT jamesrgilkerson recombinantherpesvirusglycoproteingimprovestheprotectiveimmuneresponsetohelicobacterpylorivaccinationinamousemodelofdisease
AT joannemdevlin recombinantherpesvirusglycoproteingimprovestheprotectiveimmuneresponsetohelicobacterpylorivaccinationinamousemodelofdisease
AT alisonlevery recombinantherpesvirusglycoproteingimprovestheprotectiveimmuneresponsetohelicobacterpylorivaccinationinamousemodelofdisease
_version_ 1718421896623554560